CorMedix IncNASDAQ:CRMD
- LAST PRICE4.5400
- TODAY'S CHANGE (%)-0.1700 (-3.6093%)
- Bid / Lots4.5100/ 2
- Ask / Lots4.7000/ 1
- Open / Previous Close4.7500 / 4.7100
- Day Range
- 52 Week Range
- Volume357,577
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRMD |
|---|---|---|
| 09:32 ET | 2352 | 4.75 |
| 09:34 ET | 200 | 4.71 |
| 09:36 ET | 300 | 4.73 |
| 09:38 ET | 372 | 4.745 |
| 09:39 ET | 590 | 4.74 |
| 09:43 ET | 310 | 4.75 |
| 09:48 ET | 201 | 4.74 |
| 09:50 ET | 100 | 4.74 |
| 09:54 ET | 100 | 4.74 |
| 09:56 ET | 966 | 4.76 |
| 09:57 ET | 625 | 4.775 |
| 09:59 ET | 200 | 4.76 |
| 10:01 ET | 1005 | 4.765 |
| 10:03 ET | 500 | 4.76 |
| 10:06 ET | 1400 | 4.75 |
| 10:08 ET | 2711 | 4.74 |
| 10:10 ET | 5425 | 4.71 |
| 10:12 ET | 400 | 4.73 |
| 10:14 ET | 200 | 4.72 |
| 10:15 ET | 5197 | 4.705 |
| 10:17 ET | 600 | 4.71 |
| 10:19 ET | 300 | 4.72 |
| 10:21 ET | 2260 | 4.73 |
| 10:26 ET | 800 | 4.725 |
| 10:28 ET | 100 | 4.72 |
| 10:30 ET | 100 | 4.715 |
| 10:32 ET | 4299 | 4.68 |
| 10:33 ET | 100 | 4.655 |
| 10:35 ET | 8370 | 4.6701 |
| 10:37 ET | 500 | 4.67 |
| 10:39 ET | 400 | 4.68 |
| 10:42 ET | 800 | 4.685 |
| 10:48 ET | 1486 | 4.6572 |
| 10:50 ET | 10708 | 4.67 |
| 10:51 ET | 10634 | 4.645 |
| 10:53 ET | 14443 | 4.645 |
| 10:55 ET | 400 | 4.66 |
| 10:57 ET | 200 | 4.64 |
| 11:00 ET | 100 | 4.66 |
| 11:02 ET | 112 | 4.66 |
| 11:04 ET | 201 | 4.65 |
| 11:06 ET | 100 | 4.625 |
| 11:08 ET | 500 | 4.625 |
| 11:09 ET | 293 | 4.63 |
| 11:15 ET | 800 | 4.61 |
| 11:22 ET | 200 | 4.62 |
| 11:26 ET | 300 | 4.62 |
| 11:27 ET | 23719 | 4.625 |
| 11:29 ET | 3383 | 4.635 |
| 11:31 ET | 500 | 4.655 |
| 11:33 ET | 630 | 4.64 |
| 11:36 ET | 200 | 4.63 |
| 11:38 ET | 400 | 4.64 |
| 11:42 ET | 200 | 4.65 |
| 11:44 ET | 11761 | 4.66 |
| 11:45 ET | 5356 | 4.68 |
| 11:47 ET | 2200 | 4.66 |
| 11:49 ET | 200 | 4.66 |
| 11:51 ET | 217 | 4.64 |
| 11:54 ET | 100 | 4.64 |
| 11:56 ET | 295 | 4.632 |
| 11:58 ET | 200 | 4.65 |
| 12:05 ET | 160 | 4.655 |
| 12:07 ET | 113 | 4.6499 |
| 12:09 ET | 200 | 4.65 |
| 12:12 ET | 502 | 4.64 |
| 12:14 ET | 300 | 4.62 |
| 12:18 ET | 2968 | 4.64 |
| 12:20 ET | 900 | 4.63 |
| 12:36 ET | 3599 | 4.6012 |
| 12:38 ET | 400 | 4.605 |
| 12:41 ET | 700 | 4.61 |
| 12:43 ET | 200 | 4.61 |
| 12:45 ET | 300 | 4.61 |
| 12:48 ET | 3040 | 4.626 |
| 12:50 ET | 1899 | 4.62 |
| 12:52 ET | 100 | 4.61 |
| 12:56 ET | 1077 | 4.59 |
| 12:57 ET | 180 | 4.585 |
| 12:59 ET | 100 | 4.59 |
| 01:03 ET | 700 | 4.6 |
| 01:06 ET | 500 | 4.605 |
| 01:08 ET | 100 | 4.6 |
| 01:15 ET | 100 | 4.6 |
| 01:19 ET | 2500 | 4.595 |
| 01:24 ET | 300 | 4.595 |
| 01:26 ET | 31332 | 4.585 |
| 01:28 ET | 900 | 4.58 |
| 01:30 ET | 830 | 4.575 |
| 01:32 ET | 3003 | 4.565 |
| 01:33 ET | 600 | 4.565 |
| 01:35 ET | 1920 | 4.54 |
| 01:37 ET | 2300 | 4.534 |
| 01:39 ET | 1554 | 4.53 |
| 01:42 ET | 2804 | 4.555 |
| 01:44 ET | 900 | 4.56 |
| 01:48 ET | 1100 | 4.565 |
| 01:50 ET | 4075 | 4.545 |
| 01:51 ET | 366 | 4.545 |
| 01:53 ET | 240 | 4.5477 |
| 01:55 ET | 3369 | 4.557 |
| 01:57 ET | 1100 | 4.555 |
| 02:02 ET | 200 | 4.555 |
| 02:04 ET | 800 | 4.565 |
| 02:08 ET | 1000 | 4.5685 |
| 02:09 ET | 794 | 4.5848 |
| 02:11 ET | 825 | 4.58 |
| 02:15 ET | 6054 | 4.555 |
| 02:18 ET | 420 | 4.559 |
| 02:20 ET | 1412 | 4.53 |
| 02:22 ET | 200 | 4.54 |
| 02:24 ET | 100 | 4.54 |
| 02:26 ET | 250 | 4.56 |
| 02:27 ET | 110 | 4.56 |
| 02:29 ET | 100 | 4.55 |
| 02:31 ET | 228 | 4.535 |
| 02:33 ET | 200 | 4.54 |
| 02:36 ET | 100 | 4.54 |
| 02:38 ET | 600 | 4.5528 |
| 02:40 ET | 4277 | 4.555 |
| 02:42 ET | 1450 | 4.55 |
| 02:44 ET | 1519 | 4.55 |
| 02:45 ET | 500 | 4.55 |
| 02:47 ET | 600 | 4.54 |
| 02:54 ET | 850 | 4.545 |
| 02:56 ET | 400 | 4.53 |
| 02:58 ET | 300 | 4.535 |
| 03:02 ET | 550 | 4.525 |
| 03:03 ET | 1200 | 4.5275 |
| 03:05 ET | 1900 | 4.52 |
| 03:07 ET | 4515 | 4.55 |
| 03:09 ET | 1200 | 4.545 |
| 03:16 ET | 1240 | 4.55 |
| 03:18 ET | 500 | 4.55 |
| 03:20 ET | 200 | 4.545 |
| 03:21 ET | 900 | 4.54 |
| 03:23 ET | 200 | 4.54 |
| 03:25 ET | 200 | 4.55 |
| 03:27 ET | 465 | 4.55 |
| 03:36 ET | 700 | 4.535 |
| 03:39 ET | 1611 | 4.55 |
| 03:41 ET | 642 | 4.545 |
| 03:43 ET | 520 | 4.54 |
| 03:45 ET | 100 | 4.535 |
| 03:48 ET | 1943 | 4.5427 |
| 03:50 ET | 2100 | 4.545 |
| 03:52 ET | 3773 | 4.55 |
| 03:54 ET | 1789 | 4.535 |
| 03:56 ET | 976 | 4.5322 |
| 03:57 ET | 4017 | 4.53 |
| 03:59 ET | 33545 | 4.54 |
Yesterday
DJ CorMedix Is Maintained at Buy by Truist Securities, from 10:42AM ET on Thursday Jul 25, 2024 by Dow Jones
10:42AM ET on Thursday Jul 25, 2024 by Dow Jones
Jul 3, 2024
CorMedix Inc. Announces Outpatient Availability of DefenCath, from 8:00AM ET on Wednesday Jul 03, 2024 by Dow Jones
8:00AM ET on Wednesday Jul 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
CorMedix Inc | 258.9M | -4.9x | --- |
Cipla Ltd | 14.5B | 0.0x | --- |
Zevra Therapeutics Inc | 260.7M | -4.6x | --- |
Calliditas Therapeutics AB | 1.1B | -21.1x | --- |
Incannex Healthcare Inc | 34.3M | 0.0x | --- |
Dbv Technologies SA | 93.3M | -0.7x | --- |
Company Information
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 mg/mL, and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). In addition to DefenCath, the Company has sponsored a pre-clinical research collaboration for the use of taurolidine as a possible treatment for rare pediatric tumors.
Contact Information
- Headquarters
- 300 Connell Drive, Suite 4200BERKELEY HEIGHTS, NJ, United States 07922
- Phone
- 908-517-9500
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Myron Kaplan
- Director
- Joseph Todisco
- Chief Financial Officer, Executive Vice President
- Matthew David
- Executive Vice President, Head of Clinical and Medical Affairs
- Elizabeth Massonhurlburt
- Executive Vice President, Chief Commercial Officer
- Erin Mistry
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $258.9M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 55.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.58 |
EPS | $-0.93 |
Book Value | $1.28 |
P/E Ratio | -4.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
